On Tuesday, Johnson & Johnson (JNJ) stock saw a decline, ending the day at $152.64 which represents a decrease of $-2.40 or -1.55% from the prior close of $155.04. The stock opened at $154.53 and ...
Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...
Johnson & Johnson has a high three-year median payout ratio of 71% (or a retention ratio of 29%), meaning that the company is ...
Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...
WASHINGTON (AP) — House Speaker Mike Johnson won the House Republican nomination Wednesday to stay on the job, on track to ...
The congresswoman suggested the House speaker was to blame for Republicans failing to secure a House supermajority.
President-elect Donald Trump’s endorsement of House Speaker Mike Johnson (R-La.) should put an end to any debate over his ...
Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the plan, prompting a legal battle to protect its proposed changes. Johnson & ...